Germany, Spain, and Italy have the most developed regulatory frameworks for investigational stem-cell therapies, with several university hospitals and private institutes conducting registered trials in muscular dystrophy. Poland and Czech Republic also offer active research programmes with lower cost structures. The United States has limited clinical trial capacity for muscular-dystrophy-specific stem-cell work, though the NIH and several academic centres maintain ongoing studies. United Kingdom access is primarily through National Health Service research protocols or private pay clinics. Choosing a centre should prioritise registration with ClinicalTrials.gov or EudraCT and publication of prior safety data.
Muscular dystrophy treatment costs typically range €4,000–7,500 per cycle, reflecting the need for multiple infusions and specialist neuromuscular assessment. Placental MSC sourcing and expansion for systemic administration incurs higher manufacturing expense than single-injection protocols. Disease severity and muscle group involvement influence whether local or systemic delivery is elected, affecting total cost. Many programmes require baseline and follow-up neuroimaging and strength testing, adding to overall expenses. European centres generally charge at the lower end of the range for research-protocol participation, whilst private clinics may exceed €8,000 per session.
Съм ли кандидат? → · Muscular Dystrophy: full overview → · Цена Мускулна дистрофия → · Cost →
Медицински преглед от редакционния екип на StemCellAtlas с Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) на партньорската клиника Stem Plus (София), спрямо ISSCR, FDA и EMA указания. Educational information, not medical advice; figures indicative.
GMP-сертифицирана регенеративна медицина в сърцето на ЕС — от 3 000–8 000 €, част от цените в САЩ или Германия. Персонализирани протоколи за пациенти от над 50 държави.
Безплатна медицинска оценка